Predictions
Orpea Nom.
Start price
Target price
Perf. (%)
€2.36
07.02.23
07.02.23
€4.00
07.02.24
07.02.24
9.32%
18.02.23
18.02.23
Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Sartorius Stedim Biotech S.A.
Start price
Target price
Perf. (%)
€345.00
06.02.23
06.02.23
-
06.02.24
06.02.24
-31.36%
07.02.24
07.02.24
Orpea Nom.
Start price
Target price
Perf. (%)
€2.87
05.02.23
05.02.23
-
05.02.24
05.02.24
-10.07%
18.02.23
18.02.23
Could be very worthwhile Investment >20% year
Orpea Nom.
Start price
Target price
Perf. (%)
€5.54
01.02.23
01.02.23
-
01.02.24
01.02.24
-48.21%
05.02.23
05.02.23
Could be very worthwhile Investment >20% year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€1.11
01.02.23
01.02.23
-
01.02.24
01.02.24
-0.36%
05.02.23
05.02.23
Risky Investment
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€2.81
24.12.22
24.12.22
-
24.12.23
24.12.23
-25.37%
01.11.23
01.11.23
Could be worthwhile Investment >10% per year
Oncodesign S.A.
Start price
Target price
Perf. (%)
€14.28
24.12.22
24.12.22
-
24.12.23
24.12.23
-
24.12.22
24.12.22
Could be worthwhile Investment >10% per year
Oncodesign S.A.
Start price
Target price
Perf. (%)
€14.28
23.12.22
23.12.22
-
-
24.12.22
24.12.22
Could be worthwhile Investment >10% per year
Ipsen S.A.
Start price
Target price
Perf. (%)
€105.30
08.12.22
08.12.22
€100.00
08.12.23
08.12.23
-3.04%
09.12.22
09.12.22
Could be worthwhile Investment >10% per year
Crossject S.A.
Start price
Target price
Perf. (%)
€4.04
12.11.22
12.11.22
€4.50
12.11.23
12.11.23
5.82%
13.11.23
13.11.23
Could be worthwhile Investment >10% per year
Sanofi S.A.
Start price
Target price
Perf. (%)
€88.01
01.11.22
01.11.22
€100.00
31.12.24
31.12.24
13.11%
05.05.23
05.05.23
Could be worthwhile Investment >10% per year